Clinical Trials
1
Active:0
Completed:1
Trial Phases
0 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Prevalence of Transthyretin Amyloidosis in Hypertrophic Cardiomyopathy
Completed
- Conditions
- Amyloidosis in Transthyretin (TTR)Hypertrophic Cardiomyopathy (HCM)Cardiac Amyloidosis
- First Posted Date
- 2012-06-19
- Last Posted Date
- 2019-08-14
- Lead Sponsor
- Thibaud Damy
- Target Recruit Count
- 294
- Registration Number
- NCT01623245
- Locations
- 🇫🇷
Henri Mondor Hospital, Creteil, France
News
No news found